Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2025-12-25 @ 8:39 PM
Study NCT ID:
NCT01609569
Status:
UNKNOWN
Last Update Posted:
2013-02-22
First Post:
2012-05-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pro-calcitonin Marker as Indicator of Ischemia in Patients With Complicated Coronary Intervention.
Sponsor:
Saint Michael's Medical Center
Organization:
Study Overview
Official Title:
Utility of Pro-calcitonin as an Indicator of Ischemia in Patients Undergoing Percutaneous Coronary Intervention With Subsequent Coronary Complications.
Status:
UNKNOWN
Status Verified Date:
2013-02
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to determine on preliminary basis weather an elevated pro-calcitonin level can be used to assess ischemia as a result of coronary artery complications during percutaneous coronary intervention (PCI).
Detailed Description:
Pro-calcitonin is a type of protein found in the blood. This protein has recently be found to be elevated in patients with diseases of the arteries of the heart such as heart attack.
Percutaneous coronary intervention (PCI) is widely used in the treatment of many patients with blockage in the arteries of the heart.
the investigators normally used a marker called troponin after cardiac catheterization. However, this marker may not be specific.
Pro-calcitonin has been found to be a useful marker for the detection of myocardial injury. the value of Pro-calcitonin as a marker for the identification of myocardial damage undergoing PCI has not yet been studied.
Percutaneous coronary intervention (PCI) is widely used in the treatment of many patients with blockage in the arteries of the heart.
the investigators normally used a marker called troponin after cardiac catheterization. However, this marker may not be specific.
Pro-calcitonin has been found to be a useful marker for the detection of myocardial injury. the value of Pro-calcitonin as a marker for the identification of myocardial damage undergoing PCI has not yet been studied.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: